Concord Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.67K Buy
+112
New +$9.82K ﹤0.01% 578
2026
Q1
Sell
-112
Closed -$10K 815
2025
Q4
$10K Buy
112
+1
+0.9% +$95 ﹤0.01% 539
2025
Q3
$11K Hold
111
﹤0.01% 526
2025
Q2
$10.1K Hold
111
﹤0.01% 539
2025
Q1
$12.5K Hold
111
﹤0.01% 489
2024
Q4
$11.7K Buy
111
+1
+0.9% +$107 ﹤0.01% 512
2024
Q3
$11.9K Hold
110
﹤0.01% 543
2024
Q2
$12K Hold
110
﹤0.01% 487
2024
Q1
$14.5K Sell
110
-1,310
-92% -$164K ﹤0.01% 533
2023
Q4
$173K Buy
1,420
+130
+10% +$14.5K 0.03% 214
2023
Q3
$145K Buy
1,290
+1,181
+1,083% +$150K 0.03% 230
2023
Q2
$15.9K Hold
109
﹤0.01% 541
2023
Q1
$14.1K Sell
109
-29
-21% -$3.64K ﹤0.01% 545
2022
Q4
$17.6K Buy
+138
New +$16K 0.01% 542
2022
Q3
Sell
-148
Closed -$16K 1201
2022
Q2
$16K Sell
148
-428
-74% -$50.8K ﹤0.01% 599
2022
Q1
$74K Sell
576
-81
-12% -$9.76K 0.02% 360
2021
Q4
$81K Buy
657
+524
+394% +$68.6K 0.02% 343
2021
Q3
$19K Sell
133
-402
-75% -$59.1K 0.01% 389
2021
Q2
$83K Buy
535
+76
+17% +$12.3K 0.02% 267
2021
Q1
$71K Buy
459
+455
+11,375% +$70.5K 0.02% 274
2020
Q4
$1K Buy
+4
New +$565 ﹤0.01% 666

Other funds holding ZBH

Concord Wealth Partners's ZBH Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 112 shares worth $9.67K. The stake represents ﹤0.01% of the portfolio and ranks #578 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in ZBH as recently as Q4 2025.

Concord Wealth Partners first reported a position in ZBH in Q4 2020 and has held it in 21 quarters since. The position peaked at $173K in Q4 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Concord Wealth Partners held 112 shares of Zimmer Biomet worth $9.67K as of Q2 2026.
  • Zimmer Biomet was a new Concord Wealth Partners position in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #578 holding.
  • Concord Wealth Partners first reported a position in Zimmer Biomet in Q4 2020 and has held it in 21 quarters since.
  • Concord Wealth Partners's Zimmer Biomet position peaked at $173K in Q4 2023.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.